CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Raia Drogasil S/A is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Raia Drogasil S/A
Av. Corifeu de Azevedo Marques
3.097, Butanta
Phone: +55 1137695678p:+55 1137695678 SAO PAULO, 05.339-900  Brazil Ticker: RADL3RADL3

Business Summary
Raia Drogasil S/A is a Brazil-based company, headquartered in Sao Paulo. Its main activity is the retail sale of pharmaceutical and cosmetic products, including branded medications, generic medications, OTC (over-the-counter) medications, non-medications (such as personal hygiene products, cosmetics, and dermocosmetics), and various services. The Company has a presence in all federal units of the country, demonstrating its coverage and accessibility. Additionally, the digitalization of the customer journey has been a crucial factor in the Company's growth, enabling a more convenient and efficient shopping experience. The expansion of physical pharmacies, combined with digital solutions, has significantly contributed to Raia Drogasil's continued growth in the Brazilian market.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes-Yes-

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202412/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board Antonio C.Pipponzi 70 11/10/2011 11/10/2011
Chief Executive Officer, Member of the Executive Board Renato C.Raduan 49 1/1/2024
Independent Vice Chairman of the Board Marco A.Bonomi 1/1/2022 1/1/2018
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Raia S.A. Rua Leopoldo Couto de Magalhães Junior, 758 - 3 e 4 andares Sao Paulo Brazil
4-Bio Medicamentos Ltda. Rua Pedroso Alvarenga Sao Paulo SP Brazil

Business Names
Business Name
4-Bio Medicamentos Ltda.
Drogasil SA
RADL3

General Information
Number of Employees: 64,758 (As of 12/31/2024)
Outstanding Shares: 1,711,994,628 (As of 12/31/2024)
Shareholders: 455
Stock Exchange: SAO
Fax Number: +55 1137695687


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025